Your browser doesn't support javascript.
loading
Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemia.
Lee, T C; Miller, W E; Curd, J G; Piro, L D; Saven, A.
Affiliation
  • Lee TC; Division of Hematology and Oncology, Ida M. and Cecil H. Green Cancer Center, Scripps Clinic and Research Foundation, La Jolla, California 92037, USA.
Mayo Clin Proc ; 71(10): 966-8, 1996 Oct.
Article in En | MEDLINE | ID: mdl-8820771
ABSTRACT
Essential mixed cryoglobulinemia is a systemic disorder in which cutaneous vasculitis and frequently glomerulonephritis are associated with cryoprecipitable serum immune complexes. Typically, the treatment regimen consists of plasmapheresis, high-dose corticosteroids, and cytotoxic chemotherapy, as well as interferon alfa for hepatitis C virus-related cryoglobulinemia. Herein we describe a man with progressive, symptomatic cryoglobulinemia and multisystem organ dysfunction in whom corticosteroid and alkylating therapy failed; however, he had a complete and long-lasting remission after administration of 2-chlorodeoxyadenosine (cladribine).
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Cladribine / Cryoglobulinemia / Immunosuppressive Agents Limits: Aged / Humans / Male Language: En Journal: Mayo Clin Proc Year: 1996 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Cladribine / Cryoglobulinemia / Immunosuppressive Agents Limits: Aged / Humans / Male Language: En Journal: Mayo Clin Proc Year: 1996 Document type: Article Affiliation country: United States